Literature DB >> 8892893

Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques.

A Kaur1, M D Daniel, D Hempel, D Lee-Parritz, M S Hirsch, R P Johnson.   

Abstract

Disseminated cytomegalovirus (CMV) infection is a frequent occurrence in human immunodeficiency virus-infected humans and in simian immunodeficiency virus (SIV)-infected rhesus macaques. Rhesus macaques are a suitable animal model with which to study in vivo interactions between CMV and AIDS-associated retroviruses. Since cytotoxic T lymphocytes (CTL) play a major role in control of viral infections, we have characterized CMV-specific CTL responses in SIV-infected and uninfected rhesus macaques. Autologous fibroblasts infected with rhesus CMV were used to stimulate freshly isolated peripheral blood mononuclear cells from CMV-seropositive animals. Following in vitro stimulation, specific CTL activity against CMV-infected autologous fibroblasts was detected in CMV-seropositive but not in CMV-seronegative normal macaques. CMV-specific CTL activity comparable to that in normal animals was also detected in two CMV-seropositive macaques infected with a live attenuated SIV strain (SIVdelta3) and in two of three macaques infected with pathogenic SIV strains. The CMV-specific CTL response was class I major histocompatibility complex restricted and mediated by CD8+ cells. An early CMV protein(s) was the dominant target recognized by bulk CTL, although the pattern of CTL recognition of CMV proteins varied among animals. Analysis of CMV-specific CTL responses in macaques should serve as a valuable model for CMV immunopathogenesis and will facilitate prospective in vivo studies of immune interactions between CMV and SIV in AIDS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892893      PMCID: PMC190842     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

Review 1.  Human cytomegalovirus structural proteins.

Authors:  R R Spaete; R C Gehrz; M P Landini
Journal:  J Gen Virol       Date:  1994-12       Impact factor: 3.891

Review 2.  Pathology of simian immunodeficiency virus induced disease.

Authors:  A A Lackner
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

Review 3.  Therapeutic reconstitution of human viral immunity by adoptive transfer of cytotoxic T lymphocyte clones.

Authors:  S R Riddell; P D Greenberg
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

4.  Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes.

Authors:  E McLaughlin-Taylor; H Pande; S J Forman; B Tanamachi; C R Li; J A Zaia; P D Greenberg; S R Riddell
Journal:  J Med Virol       Date:  1994-05       Impact factor: 2.327

5.  Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group.

Authors:  R D Schrier; W R Freeman; C A Wiley; J A McCutchan
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 6.  Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones.

Authors:  S R Riddell; B A Walter; M J Gilbert; P D Greenberg
Journal:  Bone Marrow Transplant       Date:  1994       Impact factor: 5.483

7.  Longitudinal study of cytomegalovirus antibodies in individuals infected with the human immunodeficiency virus.

Authors:  R W Flø; G Haukenes; A Nilsen; R Skjaerven; M Forsgren; T E Fehniger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

8.  HIV-1 DNA in fibroblast cultures infected with urine from HIV-seropositive cytomegalovirus (CMV) excretors.

Authors:  M Margalith; R T D'Aquila; D J Manion; N Basgoz; L J Bechtel; B R Smith; J C Kaplan; M S Hirsch
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

9.  Enhanced HIV-1 replication in V beta 12 T cells due to human cytomegalovirus in monocytes: evidence for a putative herpesvirus superantigen.

Authors:  D Dobrescu; B Ursea; M Pope; A S Asch; D N Posnett
Journal:  Cell       Date:  1995-09-08       Impact factor: 41.582

10.  Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.

Authors:  E A Walter; P D Greenberg; M J Gilbert; R J Finch; K S Watanabe; E D Thomas; S R Riddell
Journal:  N Engl J Med       Date:  1995-10-19       Impact factor: 91.245

View more
  31 in total

1.  Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.

Authors:  N W Blake; A Moghaddam; P Rao; A Kaur; R Glickman; Y G Cho; A Marchini; T Haigh; R P Johnson; A B Rickinson; F Wang
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Genomic sequence of rhesus cytomegalovirus 180.92: insights into the coding potential of rhesus cytomegalovirus.

Authors:  Pierre Rivailler; Amitinder Kaur; R Paul Johnson; Fred Wang
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.

Authors:  R P Johnson; R L Glickman; J Q Yang; A Kaur; J T Dion; M J Mulligan; R C Desrosiers
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Characterization of the rhesus cytomegalovirus US28 locus.

Authors:  M E T Penfold; T L Schmidt; D J Dairaghi; P A Barry; T J Schall
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells.

Authors:  C Berger; M Berger; D Anderson; S R Riddell
Journal:  J Med Primatol       Date:  2010-11-02       Impact factor: 0.667

6.  Absence of interaction between porcine endogenous retrovirus and porcine cytomegalovirus in pig-to-baboon renal xenotransplantation in vivo.

Authors:  Jay A Fishman; David H Sachs; Kazuhiko Yamada; Robert A Wilkinson
Journal:  Xenotransplantation       Date:  2018-04-06       Impact factor: 3.907

7.  Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: inverse relationship with CMV viremia.

Authors:  Amitinder Kaur; Corrina L Hale; Bradley Noren; Nadine Kassis; Meredith A Simon; R Paul Johnson
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

8.  Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.

Authors:  Kristy M Bialas; Takayuki Tanaka; Dollnovan Tran; Valerie Varner; Eduardo Cisneros De La Rosa; Flavia Chiuppesi; Felix Wussow; Lisa Kattenhorn; Sheila Macri; Erika L Kunz; Judy A Estroff; Jennifer Kirchherr; Yujuan Yue; Qihua Fan; Michael Lauck; David H O'Connor; Allison H S Hall; Alvarez Xavier; Don J Diamond; Peter A Barry; Amitinder Kaur; Sallie R Permar
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

9.  A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus.

Authors:  R C Desrosiers; V G Sasseville; S C Czajak; X Zhang; K G Mansfield; A Kaur; R P Johnson; A A Lackner; J U Jung
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

10.  Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques.

Authors:  L E Pereira; F Villinger; H Wulff; A Sankaranarayanan; G Raman; A A Ansari
Journal:  Exp Biol Med (Maywood)       Date:  2007-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.